{"id":"NCT02178956","sponsor":"Sumitomo Pharma America, Inc.","briefTitle":"A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer","officialTitle":"A Phase III Clinical Trial of BBI608 Plus Weekly Paclitaxel vs. Placebo Plus Weekly Paclitaxel in Adult Patients With Advanced, Previously Treated Gastric and Gastro-Esophageal Junction Adenocarcinoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10","primaryCompletion":"2017-09-20","completion":"2017-09-20","firstPosted":"2014-07-01","resultsPosted":"2021-05-10","lastUpdate":"2023-11-15"},"enrollment":714,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Gastric Cancer","Gastroesophageal Junction Cancer"],"interventions":[{"type":"DRUG","name":"BBI608","otherNames":["Napabucasin","BB608","BBI-608"]},{"type":"DRUG","name":"Paclitaxel","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"BBI608 plus Paclitaxel","type":"EXPERIMENTAL"},{"label":"Placebo plus Paclitaxel","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to find out whether it is better to receive a new drug, BBI608, in addition to paclitaxel chemotherapy or better to receive paclitaxel chemotherapy alone as second line treatment for gastric and gastroesophageal junction cancer after prior first line platinum and fluoropyrimidine based chemotherapy.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"36 months","effectByArm":[{"arm":"Napabucasin + Paclitaxel","deltaMin":6.93,"sd":null},{"arm":"Placebo + Paclitaxel","deltaMin":7.36,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.8596"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":19,"exclusionCount":14},"locations":{"siteCount":263,"countries":["United States","Australia","Belgium","Brazil","Bulgaria","Canada","China","Czechia","Estonia","France","Germany","Hungary","Israel","Italy","Japan","Lithuania","Poland","Romania","Russia","South Korea","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":125,"n":357},"commonTop":["Diarrhoea","Nausea","Anaemia","Abdominal pain","Decreased appetite"]}}